Glioblastoma being more reliant on OXPHOS metabolism than most cancers makes it more susceptible to OXPHOS inhibition, and these findings suggest that more could be understood about the exact mechanism by which NF-κB impacts this metabolic switch within the mitochondria [85]. Here, NFKB1 is linked to glioblastoma.